1

Investor Presentation

NEXT GEMs Conference 2020

November 4, 2020

Agenda

  • Company Overview
  • Market
  • Achievements 1H2020
  • Strategic Guidelines
  • Financials 1H2020
  • Appendix

2

Friulchem at a Glance

Friulchem a company listed at the AIM since July 2019, leading Italian operators active at international level in R&D and in the production for third party accounts (CDMO -ContractDevelopment Manufacturing Organizations) of semi-finishedand finished products containing active pharmaceutical ingredients and food supplements, specializing in drug delivery for the veterinary sector (BU VET) and in the development of dossiers for generic drugs in the Human sector (BU

Human).

The headquarter is in Milan, and the production plant is located in the industrial area of Vivaro (Friuli Venezia Giulia) authorized by the Ministry of Health and conforms to the EU GMPs to treat the class of Penicillins G (mainly amoxicillin) and sulfonamides.

3

1H2020 FINANCIAL HIGHLIGHTS

Revenues

Human €4.1 million

€7.5 million

Vet €3.4 million

EBITDA

EDBITDA

NFP

Margin

€0.03 million

€1.4 million

0.3%

MAIN CLIENTS

3

Business Unit - Vet

4

Over the years, FC has increased its field of action by developing a BU veterinary medicinal products and animal feeds / supplements, also thanks to

the strengthening of the internal R&D laboratory. The Company complies with the GMP (European Good Manufacturing Standards) EU since 2007.

Plant (Vivaro) dedicated to the production of finished end semi-finished:nutraceuticals and pharmaceutical products (granules or powders) through the following production technologies:

Plant dedicated to development and production as the result of previous investments in R&D specific systems (FC-CUBES®and FC- BALLS® ) for the administration of drugs and products/supplements both for the health of farm animals and pets.

  • Granulation: A shield to guarantee the stability of the actives in stressed conditions
  • Micronization: Micro means 100% bioavailability of the Actives in
    different finished product
  • Atomization: The best process to obtain a soluble product

NUTRACEUTICALS

PHARMACEUTICAL

- Vitamins

- Antibiotics

- Minerals

- Penicillins

- Probiotics

End-products: 1) premix (granules sent to the client in bulk for refilling or further processing on-site), 2) soluble, 3) injectable

DEDICATED TO FARM ANIMALS

FC-BALLS® TECHNOLOGY

Applicable to all finished products using water as the excipient, diluent or carrier. Allows the distribution of active ingredients, although insoluble, in all concentrations:

  • In the drinking water
  • In the pour on formulations, avoiding leaching by rain
  • Preparation of shampoos, lotions and similar
  • Environmental protection

DEDICATED TO FARM ANIMALS & PETS

FC-CUBES®TECHNOLOGY

Developed a different manufacturing method to reach a chewable matrix with all the benefits presented for the drugs. Due to the high palatability showed FC-CUBES® could be used to prepare formulations that include:

  • pharmaceutical ingredients: Antibiotics, Antiparasitic, Insecticide, Anti-inflammatory, Nutraceutical products: Additives, Vitamins, Minerals

DEDICATED TO PETS

4

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Friulchem S.p.A. published this content on 04 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2020 10:05:04 UTC